167
Views
0
CrossRef citations to date
0
Altmetric
ONCOLOGY

Surgery with postoperative radiotherapy for pN2 head and neck squamous cell carcinoma

, , , , , & show all
Pages 1104-1109 | Received 29 Apr 2013, Accepted 27 May 2013, Published online: 15 Sep 2013

References

  • Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. Head and neck cancer. N Engl J Med 1993;328:184–94.
  • Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85:95–111.
  • Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972;29:1446–9.
  • Verschuur HP, Keus RB, Hilgers FJ, Balm AJ, Gregor RT. Preservation of function by radiotherapy of small primary carcinomas preceded by neck dissection for extensive nodal metastases of the head and neck. Head Neck 1996;18:277–82.
  • Byers RM, Clayman GL, Guillamondequi OM, Peters LJ, Goepfert H. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract. Head Neck 1992;14:133–8.
  • Smeele LE, Leemans CR, Reid CB, Tiwari R, Snow GB. Neck dissection for advanced lymph node metastasis before definitive radiotherapy for primary carcinoma of the head and neck. Laryngoscope 2000;110:1210–14.
  • Vokes EE, Stenson K, Rosen FR, Kies MS, Rademaker AW, Witt ME, et al. Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. J Clin Oncol 2003;21:320–6.
  • Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy – results of multicentric randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2001;50:1161–71.
  • Urba SG, Wolf GT, Bradford CR, Thornton AF, Eisbruch A, Terrell JE, et al. Neoadjuvant therapy for organ preservation in head and neck cancer. Laryngoscope 2000;110:2074–80.
  • Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, et al. ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer 2008;99:167–72.
  • Fletcher GH, Shukovsky LJ. The interplay of radiocurability and tolerance in the irradiation of human cancers. J Radiol Electrol Med Nucl 1975;56:383–400.
  • Parsons JT, Mendenhall WM, Cassisi NJ, Stringer SP, Million RR. Neck dissection after twice a day radiotherapy: morbidity and recurrence rates. Head Neck 1989;11:400–4.
  • Pfister D, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK, et al. American Society of Clinical Oncology Practice Guidelines for the use of larynx preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 2006;24:3693–704.
  • Abitbol AA, Friedland JL, Lewin AA, Rodrigues M, Mishra V. 1999. Radiation therapy in oncologic management with special emphasis on head and neck carcinoma. In Sullivan PA, Guilford AM, editors. Swallowing intervention in oncology. San Diego: Singular Publishing Group, Inc. p 47–64.
  • Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 2005;27:843–50.
  • Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571–8.
  • Rosenthal DI, Liu L, Lee JH, Vapiwala N, Chalian AA, Weinstein GS, et al. Importance of treatment package time in surgery and postoperative radiation therapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:115–26.
  • Johnson JT, Myers EN, Bedetti CD, Bedetti EL, Schramm VL, Thearle PB. Cervical lymph node metastasis – incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985;111:534–7.
  • Joo YH, Cho KJ, Park JO, Nam IC, Kim MS. Factors influencing the outcomes of primary surgery with postoperative radiotherapy for pN2 oropharyneal squamous cell carcinoma. Oral Oncol 2012;48:90–4.
  • León X, Quer M, Orús C, del Prado Venegas M, López M. Distant metastases in head and neck cancer patients who achieves local-regional control. Head Neck 2000;22:680–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.